<DOC>
	<DOCNO>NCT00442351</DOCNO>
	<brief_summary>This randomize , multicenter , placebo-controlled , double-blind , parallel-group study evaluate Asmanex Twisthaler 220 mcg daily ( QD ) evening ( PM ) compare `` Asmanex '' Placebo QD PM 12 week . Efficacy measure change force expiratory volume 1 second ( FEV1 ) baseline end treatment period ( Week 12 end study ) .</brief_summary>
	<brief_title>Efficacy Tolerability Maintenance Treatment With Asmanex Twisthaler Versus Placebo Mild/Moderate Persistent Asthmatics ( Study P04654 ) ( TERMINATED )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<criteria>Sign inform consent Be 1875 year age , either sex race Have asthma &gt; = 12 month Have mild moderate persistent asthma Prior complete Screening Visit procedure , must use : low moderate dos inhale corticosteroid ( IC ) , shortacting beta2 agonist ( SABA ) need ( prn ) SABA prn monotherapy . Those use combination ICs plus longacting beta2 agonist ( LABA ) medication , Advair 100/50 twice daily ( BID ) , must change fluticasone propionate 100 mcg BID least 5 day prior start RunInPeriod . Those use LABA monotherapy must switch SABA prn least 5 day prior start RunIn Period Be treatment leukotriene receptor antagonist ( LTRA ) least 14 day prior Screening Have FEV1 &gt; =65 % &lt; =85 % predict normal value Screening Baseline SABAs withhold least 6 hour Demonstrate increase absolute FEV1 &gt; = 12 % absolute volume increase least 200mL Screening . Written documentation FEV1 reversibility &gt; = 12 % within 2 year prior Screening acceptable lieu test . FEV1 reversibility test do withholding inhale SABA least 6 hour Have frequency asthma score least 2 ( least 2 symptom ) and/or frequency bronchodilator use score least 2 Screening Have Total Asthma Severity Score ( TASS ) least 4 8 AM PM recording last 7 day Runin period prior Baseline AM Baseline Visit At Screening Visit , sleep disturbance score &gt; =2 interference sleep rating scale ( recall past 7 night ) , least 30 Medical Outcomes Study Sleep scale ( MOSSS ) Sleep Disturbance Sleep Scale ( recall past 7 day ) At Baseline Visit , must sleep disturbance score &gt; = 2 interference sleep rating scale ( record diary past 7 night ) , least 30 MOSSS Sleep Problems Index II 9 item ( SLP 9 ) Exclusion Criteria Women pregnant intend become pregnant study Women nurse intend nurse study within 30 day completion Have participate clinical trial within last 30 day one involve antibody asthma rhinitis within 3 month prior Screening Have unscheduled medical visit ( due exacerbation asthma ) within 1 month prior Screening Have treat emergency room admit hospital due exacerbation asthma two occasion within 12 month prior Screening Have use &gt; 12 puff rescue SABAs 2 treatment nebulized beta2agonist per day 2 consecutive day within 4 week prior Screening Required 2 course oral/systemic corticosteroid asthma within 12 month prior Screening Have history sleep disorder , include narcolepsy , use medication affect alertness sleep Have sleep apnea , obstructive sleep apneahypopnea , treat ventilation device Continuous Positive Airway Pressure ( CPAP ) ( Bilevel Positive Airway Pressure ( BiPAP ) , receive oxygen inhalation Are smokers exsmokers smoke within 6 month prior Screening cumulative smoking history 10 packyears great Are allergic corticosteroid , SABAs , LABAs Required ventilator support respiratory failure secondary asthma last 10 year Have BodyMassIndex great 35</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>